Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GEHC
GEHC logo

GEHC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy GE Healthcare Technologies Inc (GEHC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
61.590
1 Day change
0.72%
52 Week Range
89.770
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

GE Healthcare Technologies Inc (GEHC) does not present a compelling buy opportunity for a beginner investor with a long-term horizon at this time. The stock is currently under pressure due to macroeconomic challenges, rising input costs, and a weaker-than-expected earnings outlook. While insiders are buying and the stock has potential for long-term growth, the lack of strong positive catalysts and bearish technical indicators suggest a wait-and-see approach is more prudent.

Technical Analysis

The technical indicators are bearish. The MACD histogram is negative and expanding downward, RSI is neutral but leaning toward oversold territory, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 60.983) with resistance levels at R1: 65.926 and R2: 67.453.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market, but the overall trading volume is relatively low, suggesting limited conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Insiders are buying, with a significant increase of 1425.73% in insider purchases over the last month. Congress trading data shows balanced activity, with one purchase transaction. The stock has an 80% chance of gaining 10.99% in the next month based on historical candlestick patterns.

Neutral/Negative Catalysts

  • Hedge funds are selling, with a 129.92% increase in selling activity over the last quarter. Analysts have significantly lowered price targets across the board, citing weaker margins, inflationary pressures, and macroeconomic challenges. The company also missed Q1 earnings and reduced its 2026 EPS guidance.

Financial Performance

No detailed financial data is available for analysis, but analysts have highlighted weaker-than-expected Q1 earnings and reduced 2026 EPS guidance due to rising input costs and macroeconomic headwinds.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have downgraded the stock and lowered price targets significantly. The consensus is mixed, with some maintaining Outperform ratings, but many have shifted to Neutral or downgraded the stock. The reduced earnings outlook and macro pressures are key concerns, despite some long-term growth potential.

Wall Street analysts forecast GEHC stock price to rise
13 Analyst Rating
Wall Street analysts forecast GEHC stock price to rise
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 61.150
sliders
Low
80
Averages
92.25
High
105
Current: 61.150
sliders
Low
80
Averages
92.25
High
105
Evercore ISI
Outperform
to
Outperform
downgrade
$85 -> $80
AI Analysis
2026-04-30
Reason
Evercore ISI
Price Target
$85 -> $80
AI Analysis
2026-04-30
downgrade
Outperform
to
Outperform
Reason
Evercore ISI lowered the firm's price target on GE HealthCare to $80 from $85 and keeps an Outperform rating on the shares.
JPMorgan
Robbie Marcus
Neutral
downgrade
$80 -> $65
2026-04-30
Reason
JPMorgan
Robbie Marcus
Price Target
$80 -> $65
2026-04-30
downgrade
Neutral
Reason
JPMorgan analyst Robbie Marcus lowered the firm's price target on GE HealthCare to $65 from $80 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GEHC
Unlock Now

People Also Watch